Filing Details

Accession Number:
0001022079-20-000192
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-24 16:31:08
Reporting Period:
2020-11-23
Accepted Time:
2020-11-24 16:31:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221534 Daniel Stanzione 500 Plaza Drive
Secaucus NJ 07094
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-23 5,621 $125.73 33,951 No 4 S Direct
Common Stock Disposition 2020-11-23 3,302 $126.46 30,649 No 4 S Direct
Common Stock Disposition 2020-11-23 2,300 $127.45 28,349 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $125.09 to $126.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $126.09 to $127.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $127.12 to $127.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.